H. A. Fine

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Jeffery J. Raizer, L. E. Abrey, Andrew B. Lassman et al. · Neuro-Oncology · 2009 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

Fábio M. Iwamoto, Kathleen R. Lamborn, H. I. Robins et al. · Neuro-Oncology · 2010 · 219 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri Kreisl, Wei Zhang, Yazmín Odia et al. · Neuro-Oncology · 2011 · 115 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A phase I/II trial of vandetanib for patients with recurrent malignant glioma

T. N. Kreisl, K. McNeill, Joohee Sul et al. · Neuro-Oncology · 2012 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas

Teri T. Ngo, Tien Peng, Xing‐Jie Liang et al. · JNCI Journal of the National Cancer Institute · 2007 · 71 citations

Medicine, Molecular Biology, Oncology +16